posted February 25, 2022 07:07 am by AviseAnalytics
(4)
$KOD Kodiak Sciences, Inc. (NASDAQ: KOD), a clinical-stage biotechnology Company focused on creating novel therapeutics for the treatment of retinal diseases announced disappointing results
...read more